
Insights from 2024 ATS Annual Meeting
Playback speed
10 seconds
ATS 2024 Insights: Interim Results From the Phase 1B and Phase 2 TORREY Open-Label Extension Study of Seralutinib in PAH
By
Insights from 2024 ATS Annual Meeting
FEATURING
Olivier Sitbon
By
Insights from 2024 ATS Annual Meeting
FEATURING
Olivier Sitbon
0 views
June 18, 2024
Comments 0
Login to view comments.
Click here to Login
Videos